2008-March Archives by Date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Mon Mar 3 06:54:02 2008
Ending: Mon Mar 31 14:54:01 2008
Messages: 149

• [Ip-health] 45 approved Development Agenda recommendations   Thiru Balasubramaniam
• [Ip-health] Fwd: [Random-bits] Access to medicine in developing countries -- ho ping for change   proclus@gnu-darwin.org
• [Ip-health] WSJ: GlaxoSmithKline to Stop Selling, Developing Malaria Drugs   Matt Price
• [Ip-health] GNU-Darwin: current best recommendation   Jeffrey A. Williams
• [Gnu-darwin-distribution] [Ip-health] GNU-Darwin: current best recommendation   Jeffrey A. Williams
• [Ip-health] IHT: Head of Thailand's FDA resigns after one week   Judit Rius Sanjuan
• [Ip-health] WIPO: first post on the A2K Brasil website   Pedro Moniz
• [Ip-health] Re: [A2k] 45 approved Development Agenda recommendations   Gwen Hinze
• [Gnu-darwin-distribution] [Ip-health] GNU-Darwin: current best recommendation   proclus@gnu-darwin.org
• [Ip-health] Bush Administration response to Senate Patent Reform Bill   Matthew Rimmer
• [Ip-health] U.S. Journalists that covered trade disputes involving medicines, before the 1999 Gore zaps   Maria F Jorge
• [Ip-health] RE: [A2k] 45 approved Development Agenda recommendations   Uhlir, Paul
• [Ip-health] Thai Minister says Commerce Min. to decide w/in 2 weeks re implementing cancer CLs   Sarah Rimmington
• [Ip-health] KEI intervention at the WIPO Committee on Development and Intellectual Property (CDIP)   Thiru Balasubramaniam
• [Ip-health] FromGeneva: New WIPO committee on Development Agenda gets underway   Thiru Balasubramaniam
• [Ip-health] Documentation for IGWG POA Meeting   Judit Rius Sanjuan
• [Ip-health] ITPC Antiretrovirals Becoming More Profitable for Pharmaceutical Industry, Los Angeles Times Reports   Michelle Childs
• [Ip-health] RE: [A2k] 45 approved Development Agenda recommendations   Uhlir, Paul
• [Ip-health] Email alert: March issue of the WHO Bulletin   bulletin
• [Ip-health] [From: Spring Gombe] Drug firms pressed on secret pill data   Guardian Unlimited
• [Ip-health] New York Times: Eradicate Malaria? Doubters Fuel Debate   Thiru Balasubramaniam
• [Ip-health] Intellectual Property v. Human Rights? Panel Discussion, 13 March, Geneva   Caroline Dommen
• [Ip-health] Science: New Prize sends Old Hands on Flights of Lunar Discovery   Suerie Moon
• [Ip-health] Tequila, Mexico and the WIPO leadership race   Thiru Balasubramaniam
• [Ip-health] ICTSD vacancy - Programme Officer on Intellectual Property   =?ISO-8859-1?Q?Mar=EDa_Julia_Oliva?=
• [Ip-health] EU commission musical chairs begins in Brussels   Michelle Childs
• [Ip-health] NYTimes: More Expensive Placebos Bring More Relief   peter maybarduk
• [Ip-health] WHO IGWG: Comments by Member States   Judit Rius Sanjuan
• [Ip-health] No cancellation of CL for cancer drugs : Chaiya   Ellen 't Hoen
• [Ip-health] KEI Letter to Thailand Prime Minister and Health Minister, regarding compulsory licensing decisions   James Love
• [Ip-health] WIPO: Discussion begins on implementing the Development Agenda   Sangeeta
• [Ip-health] Generic drug debate intensifies   Kannikar KIJTIWATCHAKUL
• [Ip-health] KES Interview - Five Questions for James Boyle   James Love
• [Ip-health] HR4279: Worrying IP Legislation   Ethan Guillen
• [Ip-health] UK: Drugs firms face new laws on test results   Spring Gombe
• [Ip-health] Drug Prices Climbing, AARP Says (2.5 times inflation)   Riaz K Tayob
• [Ip-health] Letter to Editor from Thai Network of People Living with HIV/AIDS, concerning "Bangkok's Drug War, Round Two"   Kannikar KIJTIWATCHAKUL
• [Ip-health] KEI blog: Colombian Submission to the WHO IGWG negotiation   Judit Rius Sanjuan
• [Ip-health] Patients, activists rally for removal of Chaiya   Kannikar KIJTIWATCHAKUL
• [Ip-health] HR4279: Worrying IP Legislation   William New
• [Ip-health] UK Company accused of cheating NHS   Riaz K Tayob
• [Ip-health] USTR: "Time is now" on Colombia FTA   Judit Rius Sanjuan
• [Ip-health] Letter from Colombian civil society against amendment of Decision 486   Judit Rius Sanjuan
• [Ip-health] Abbott Labs & others settle case filed by consumers and insurance cos for inflating prices   Sarah Rimmington
• [Ip-health] Health Ministry to push for discounts   Kannikar KIJTIWATCHAKUL
• [Ip-health] Drug giants 'swindle NHS by blocking cheap medicines' extending patents   Ira Glazer
• [Ip-health] Financial Times: Seroxat lessons   Spring Gombe
• [Ip-health] EU to ask WTO to rule on Thailand's drug licensing- The Nation   Alexandra HEUMBER
• [Ip-health] Steven Wiley, It's Not Just About Innovation: New ideas are cheap; what we really need are scientists who can see them through   James Love
• [Ip-health] WIPO Leadership Race - Part II: Learning from the Idris Era without being Held Hostage to his Legacy   Sisule F. Musungu
• [Ip-health] Bolivian civil society against amendment of Decision 486   Judit Rius Sanjuan
• [Ip-health] Reports: Thailand to proceed with cancer CLs   robert weissman
• [Ip-health] Drug giant Pfizer tries to force medical journal to reveal anonymous sources   Ira Glazer
• [Ip-health] WSJ: Thai Ministry to Recommend Ignoring Patents on Cancer Drugs   Judit Rius Sanjuan
• [Ip-health] EU to ask WTO to rule on Thailand's drug licensing- The Nation   =?ISO-8859-1?Q?J=E9r=F4me?= Martin
• [Ip-health] Urgent request for Applications for Short term consultants on product and service donations   mkamalyanni@Oxfam.org.uk
• [Ip-health] SUNS: Development Agenda meeting ends, slow progress on implementation   Sangeeta
• [Ip-health] A Solution to Corruption and Inefficiency in Drug Trials   Liz Chimienti
• [Ip-health] NYT: Bottom-Line Philanthropy   Matt Price
• GNU-Darwin Action Alert: [Ip-health] Drug giant Pfizer tries to for ce medical journal to reveal anonymous sources   proclus@gnu-darwin.org
• [Ip-health] Note: EU confirms legality of Thai medicines policy; denies threatening WTO litigation   Sarah Rimmington
• [Ip-health] Index of Submissions to USTR for 2008 Special 301 Report   Mike Palmedo
• [Ip-health] Drug Firms Woo Democrats, Helping Defeat Their Bills   Stephanie Burgos
• [Ip-health] IFMSA policy statement on situation in Thailand re Abbott and CL   Rachel Kiddell-Monroe
• [Ip-health] A Solution to Corruption and Inefficiency in Drug T rials   proclus@gnu-darwin.org
• [Ip-health] Data on Thai Compulsory License Benefits   robert weissman
• [Ip-health] Thai Govt Pharma Org plans to manufacture heart, Aids drugs   Sarah Rimmington
• [Ip-health] Selected recent Thai & International coverage of Thai medicines policy   Sarah Rimmington
• [Ip-health] AEI mag: =?windows-1252?Q?Thailand=92s_Drug_Wars=3A_The_?= =?windows-1252?Q?military_junta_abused_intellectual_property_r?= =?windows-1252?Q?ights_and_harmed_trade_relations=2E_What_wi?= =?windows-1252?Q?ll_the_new_government_do=3F?=   Sarah Rimmington
• [Ip-health] Note: EU confirms legality of Thai medicines policy; denies threatening WTO litigation   James Love
• [Ip-health] A Solution to Corruption and Inefficiency in Drug T rials   Dean Baker
• [Ip-health] EU to ask WTO to rule on Thailand's druglicensing- The Nation   Richard Elliott
• [Ip-health] Pharmalot: EU Not Threatening Thailand With WTO Litigation   Sarah Rimmington
• [Ip-health] Guardian: EU summit unlikely to amend the Lisbon strategy of putting European competitiveness ahead of social goals   Sarah Rimmington
• [Ip-health] WSJ ASIA: Letters to the Editor Debating Thailand's Drug Patent Policies   Ellen T HOEN
• [Ip-health] IP-Watch Inside views by Ahmed Abdel Latif - Linkages between the WIPO Development Agenda and the TRIPS Council   Sisule Musungu
• [Ip-health] Re: US Medical Device Companies, Kick Backs and Regulation   Tom Faunce
• [Ip-health] EU to ask WTO to rule on Thailand's druglicensing- The Nation   Alexandra HEUMBER
• [Ip-health] Why no states used WTO scheme for CL ? Research paper (Monash Uni, AUS)   Rachel Kiddell-Monroe
• [Ip-health] IP Watch on Roche participating in Indian CL hearing   Judit Rius Sanjuan
• [Ip-health] India's WSJ: Sanofi reiterates threat to sue Indian co. planning to export clopidogrel to Thais; is "optimistic" it will reach deal with Thailand in price negotiations   Sarah Rimmington
• [Ip-health] Drug Maker Stays Close to Doctors and Patients   Joana Ramos
• [Ip-health] Cutting Dosage of Costly Drug Spurs a Debate   Joana Ramos
• [Ip-health] SIP Seminar: Reflections on formulating Chinese IP Policies, 12 March 2008   south@southcentre.org
• [Ip-health] USTR to meet with Thai Officials on Compulsory Licenses - report   robert weissman
• [Ip-health] =?windows-1252?Q?THURSDAY=3A_United_Nations_University_p?= =?windows-1252?Q?anel_discussion=3A_=22Prize_or_Patent=3F_Inno?= =?windows-1252?Q?vative_Ideas_for_Funding_Medical_Drug_Devel?= =?windows-1252?Q?opment_and_Access=94?=   Malini Aisola
• [Ip-health] BNA: Republicans Ask for Hearing on Patent Reform Bill's International Impact   Mike Palmedo
• [Ip-health] MIT: Solving the drug price crisis by separating drug discovery from drug marketing   Judit Rius Sanjuan
• [Ip-health] Eyeing Coverage: Ontario Blinks Over Lucentis   Joana Ramos
• [Ip-health] TACD letter to Susan Schwab and Peter Mandelson regarding Thailand compulsory licensing dispute   James Love
• [Ip-health] the latest comment from the US on the CL issue   Kannikar KIJTIWATCHAKUL
• [Ip-health] Re: [thaifta] the latest comment from the US on the CL issue   B.Baker@neu.edu
• [Ip-health] Re: [thaifta] the latest comment from the US on the CL issue   michael.davis@law.csuohio.edu
• [Ip-health] Fwd: IP-Watch's Questions to WIPO DG Candidates   Sisule Musungu
• [Ip-health] Sun-Sentinel op-ed: Compulsory licenses the right medicine for prescriptions in developing countries   Sarah Rimmington
• [Ip-health] 18 states sue Abbott for blocking generic cholesterol drug   Mike Palmedo
• [Ip-health] KEI Comments on the ACTA (Anti-Counterfeiting agreement) request for comment by USTR   James Love
• [Ip-health] KEI issues report on Selected Innovation Prizes and Reward Programs   James Love
• [Ip-health] Biopharmaceutical Product FDA Approvals Study Published   Biotech. Info. Inst.
• [Ip-health] Natco's application for CL for Export - Hearing in the Delhi Patent Office   chan park
• [Ip-health] WIPO Leadership Race - Outsiders versus Insiders: Who woul be a better DG?   Sisule Musungu
• [Ip-health] IQsensato on WIPO Leadership Race Part III -Outsiders versus Insiders: Who Would be a Better DG   Sisule F. Musungu
• [Ip-health] GSK price discrim w/IN countries   Sean Flynn
• [Ip-health] Bridges: US to resume trade talks with Thailand, Malaysia   Sarah Rimmington
• [Ip-health] USTR, Thai Officials discuss CL, but not FTA   Judit Rius Sanjuan
• [Ip-health] Cipla allowed by Indian Court to continue manufacture of Roche's Tarceva   amit sen
• [Ip-health] Essential Action Comments on the Anti-Counterfeiting Trade Agreement   peter maybarduk
• [Ip-health] =?WINDOWS-1252?Q?L=92acc=E8s_aux_m=E9dicaments_sous_le_nouveau_r?= =?WINDOWS-1252?Q?=E9gime_de_protection_:_cas_du_sida_au_Maroc?=   Manon Ress
• [Ip-health] Ron Marchant: Managing Prize Systems: Some Thoughts on the Options   Manon Ress
• [Ip-health] Health Canada Issues Draft Guidance For Biologics and details re new US Biologics bill   Sarah Rimmington
• [Ip-health] Thailand: EU Complains Again About Affordable Medicine   Michelle Childs
• [Ip-health] Op-ed in IL newspaper: Thailand's misuse of 'compulsory licensing' allowed corrupt officials to steal millions   Mike Palmedo
• [Ip-health] France: Prescription drugs mean big money   michelle.childs@keionline.org
• [Ip-health] Workshop: The Process and Impact of the WHO Intergovernmental Working Group on Public Health, Innovation and Intellectual Property   Karsten Gerloff
• [Ip-health] Op-Ed: Drug Patent Rules Must Allow Exceptions for Public Health   Dan Beeton
• [Ip-health] Sticker shock a side effect of cancer remedies   Joana Ramos
• [Ip-health] Abbott's compulsory license on the Innogenetics's patents for hepatitis C virus (HCV) testing kit   James Love
• [Ip-health] NYT: Cigarette Company Paid for Lung Cancer Study   Matt Price
• [Ip-health] PRESS RELEASE: SciDev.Net looks at the antibiotic time bomb   SciDev.Net
• [Ip-health] Prizes, not prices, to stimulate antibiotic R&D   James Love
• [Ip-health] Switzerland to Thailand, drop dead   James Love
• [Ip-health] Sally Pipes: Thailand's Misuse of 'Compulsory Licenses'   B.Baker@neu.edu
• [Ip-health] Prize money could stimulate medical research   Judit Rius Sanjuan
• [Ip-health] NYT: Cigarette Co. Paid for Lung Cancer Study   Suerie Moon
• [Ip-health] Business Standard (India) Editorial: Cancer patents   Sarah Rimmington
• [Ip-health] Cigarette Company Paid for Lung Cancer Study   Joana Ramos
• [Ip-health] Thailand: EU Complains Again About Affordable Medicine   Miles Teg
• [Ip-health] SUNS: Slow progress in talks on IPRs and innovation   Sangeeta
• [Ip-health] Roche seeks US compulsory license on anemia drugs   robert weissman
• [Ip-health] Thailand: EU Complains Again About Affordable Medicine   michael.davis@law.csuohio.edu
• [Ip-health] Conference Call: State Policy Options for Prescription Drug Reform   Joana Ramos
• [Ip-health] IP-Watch: Industry Losing Faith In WIPO; Debates US WTO Cases Against China   Thiru Balasubramaniam
• [Ip-health] 83 countries determine the fate of WIPO (ie-who will be the new DG)?   Thiru Balasubramaniam
• [Ip-health] SUNS: Slow progress in talks on IPRs and innovation   mko
• [Ip-health] SUNS: Slow progress in talks on IPRs and innovation   Sangeeta
• [Ip-health] Delhi High Court Rules in Favour of Treatment Access   Kajal Bhardwaj
• [Ip-health] Selgelid on TB   Aidan Hollis
• [Ip-health] Roche seeks compulsory license for Amgen patent, in US   James Love
• [Ip-health] Microsoft receives a compulsory license on Patent 5,293,615 for MS Office suite   James Love
• [Ip-health] IP-Watch: WIPO Director General Candidates Answer 5 Questions On IP Policy   Thiru Balasubramaniam
• [Ip-health] WIPO Decision on Program and Budget (Budget Approved)   Thiru Balasubramaniam
• [A2k] Re: [Ip-health] SUNS: Slow progress in talks on IPRs and innovation   Miles Teg
• [Ip-health] Financial Times: The man who battled big pharma   Thiru Balasubramaniam
• [Ip-health] USTR Nat. Trade Barriers Report on Thai compulsory licenses   Mike Palmedo
• [Ip-health] Indian Non-Profit Wants To Break Cancer Patents   Joana Ramos
• [Ip-health] S KOREAN GROUP TO ASK FOR CHEAPER ACCESS TO NOVARTIS DRUG   Joana Ramos
• [Ip-health] USTR Nat. Trade Barriers Report on Thai compulsory licenses   michael.davis@law.csuohio.edu
• [Ip-health] Indian cancer group to seek compulsory licensing of cancer drugs   robert weissman
• [Ip-health] The Star (Malaysia): Fighting for cheap heart, cancer drugs   Sarah Rimmington

Last message date: Mon Mar 31 14:54:01 2008
Archived on: Mon Mar 31 14:54:01 2008

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...